1. Home
  2. EXLS vs GKOS Comparison

EXLS vs GKOS Comparison

Compare EXLS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXLS
  • GKOS
  • Stock Information
  • Founded
  • EXLS 1999
  • GKOS 1998
  • Country
  • EXLS United States
  • GKOS United States
  • Employees
  • EXLS N/A
  • GKOS N/A
  • Industry
  • EXLS Business Services
  • GKOS Medical/Dental Instruments
  • Sector
  • EXLS Consumer Discretionary
  • GKOS Health Care
  • Exchange
  • EXLS Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • EXLS 6.5B
  • GKOS 5.4B
  • IPO Year
  • EXLS 2006
  • GKOS 2015
  • Fundamental
  • Price
  • EXLS $39.38
  • GKOS $84.04
  • Analyst Decision
  • EXLS Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • EXLS 4
  • GKOS 13
  • Target Price
  • EXLS $54.50
  • GKOS $122.08
  • AVG Volume (30 Days)
  • EXLS 1.5M
  • GKOS 1.5M
  • Earning Date
  • EXLS 10-28-2025
  • GKOS 10-29-2025
  • Dividend Yield
  • EXLS N/A
  • GKOS N/A
  • EPS Growth
  • EXLS 29.94
  • GKOS N/A
  • EPS
  • EXLS 1.48
  • GKOS N/A
  • Revenue
  • EXLS $2,026,490,000.00
  • GKOS $469,820,000.00
  • Revenue This Year
  • EXLS $14.78
  • GKOS $30.89
  • Revenue Next Year
  • EXLS $11.33
  • GKOS $24.36
  • P/E Ratio
  • EXLS $26.72
  • GKOS N/A
  • Revenue Growth
  • EXLS 14.43
  • GKOS 30.38
  • 52 Week Low
  • EXLS $37.30
  • GKOS $73.16
  • 52 Week High
  • EXLS $52.43
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • EXLS 38.94
  • GKOS 51.85
  • Support Level
  • EXLS $38.20
  • GKOS $83.46
  • Resistance Level
  • EXLS $40.73
  • GKOS $102.80
  • Average True Range (ATR)
  • EXLS 1.06
  • GKOS 5.52
  • MACD
  • EXLS -0.11
  • GKOS 1.01
  • Stochastic Oscillator
  • EXLS 43.48
  • GKOS 37.31

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: